.png){kind=icon}
P
Piotr Jankowski
H-index:42
Citation Count:4.2万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Metabolic and Bariatric Surgery and Bone Mineral Density: A 9-Year Prospective Study
代谢与减肥手术对骨密度的影响：一项为期9年的前瞻性研究
Obesity Surgery
IF3.1
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
欧洲心脏学会关于冠状动脉心脏病的预防与康复指南及当前实践：EUROASPIRE VI调查
European Heart Journal
IF35.6
Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries
冠心病患者的高血压知晓率、治疗率及控制率：27个国家EUROASPIRE V调查结果
Risk assessment of cardiac arrhythmias in the early post-COVID-19 period in non-hospitalized patients—long-term data from the PoLoCOV-CVD study
新冠病毒感染后早期非住院患者心律失常的风险评估——PoLoCOV-CVD研究的长期数据
Scientific Reports
IF3.9
Association Between Lipid-Lowering Therapy and Differences in the Distribution of LDL-C, apoB and non-HDL-C
血脂降低疗法与LDL-C、apoB和non-HDL-C分布差异之间的关系
Is a Single Lipoprotein(a) Measurement Once in a Lifetime Sufficient? The Results from the STAR-Lp(a) Study
单次Lipoprotein(a)测量终身是否足够？STAR-Lp(a)研究的结果
Medical Sciences
IF4.4
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
焦虑和抑郁与冠心病二级预防在六个WHO区域14个国家的相关性：INTERASPIRE研究
Sociodemographic, disease-related and lifestyle determinants of health-related quality of life among older patients hospitalized with heart failure
老年心力衰竭住院患者健康相关生活质量的社会人口学、疾病相关及生活方式影响因素
Scientific Reports
IF3.9
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE
心血管疾病患者Lp(a)检测与管理的医师观点：INTERASPIRE项目五个世界卫生组织区域七个国家的访谈
Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions
患者对脂蛋白(a)检测和治疗用于心血管疾病二级预防的看法：来自INTERASPIRE研究在五个世界卫生组织区域七个国家的结果
Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position
连续血糖监测系统可在2型糖尿病个体中应对血糖管理的挑战并实现更多目标：一项专家多学科立场
Diabetes Therapy
IF2.6
Long-term trends in cardiovascular risk factors and cardiovascular risk following bariatric surgery: A 10-year prospective cohort study
接受减重手术后心血管风险因素及心血管风险的长期趋势：一项为期10年的前瞻性队列研究
ATHEROSCLEROSIS
IF5.7
Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE
13个国家6个WHO区域冠心病患者中，残余性混合型高脂血症和高三酰甘油血症的患病频率：INTERASPIRE研究的结果
ATHEROSCLEROSIS
IF5.7
IMPLEMENTATION OF THE GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION AMONG PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE. RESULTS FROM THE POLASPIRE I AND II SURVEYS
高血压管理指南在已确诊冠心病患者中的实施。POLASPIRE I 和 II 调查的结果
